Peak Proteins Ltd.

https://www.peakproteins.com

LinkedIn: https://www.linkedin.com/company/peak-proteins-ltd-

Peak Proteins is a rapidly growing contract research organisation that provides three key services; tailor-made protein reagents, protein structure information using X-ray crystallography and protein mass spectrometry. Founded in 2014 by Dr Mark Abbott, they are based in recently acquired purpose-build research facilities at Tytherington Business Park in Cheshire UK. The company employs 35 staff, most of whom have years of drug discovery experience and in-depth scientific knowledge needed to produce bespoke protein reagents suitable for use in a wide variety of applications. Their crystallography team are highly skilled in crystallography and interpretation of protein X-ray structure data working with medicinal chemistry design teams to fully exploit structural information. in the pharmaceutical and biotechnology industries. They have an excellent record of successful and timely delivery, working collaboratively with partners in pharmaceutical and biotechnology industries. Their strong, interactive client relationships has led to their rapid, global growth. *

	Start	2014-01-01 established
	Group	Sygnature Discovery (Group)
	Industry	drug discovery services
	Industry 2	structural proteomics
	Person	Abbott, Mark (Peak Proteins 202204 CEO)

	Region	Macclesfield, Cheshire
	Country	United Kingdom (GB)
	Street	Larkwood Way Birchwood House
	City	SK10 2XR Macclesfield
	Tel	+44-1625-919726
		Address record changed: 2024-01-05

Basic data	Employees	B: 11 to 50 (2022-04-26)

		* Document for »About Section«: Sygnature Discovery Ltd.. (4/26/22). "Press Release: Sygnature Discovery Acquires Peak Proteins, to Strengthen Its Drug Discovery Capabilities". Nottingham.

		Record changed: 2023-07-10

Picture EBD Group BIO-Europe 2024 Stockholm from 14 Sep 650x200px

More documents for Sygnature Discovery (Group)

[1] Sygnature Discovery Ltd.. (4/26/22). "Press Release: Sygnature Discovery Acquires Peak Proteins, to Strengthen Its Drug Discovery Capabilities". Nottingham....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com